Alcoholic beverages and prostate cancer in a prospective US cohort study.
Despite numerous investigations, the correlation between alcohol consumption and prostate cancer risk remains uncertain. This report investigated the association between alcohol use and prostate cancer risk in a prospective cohort study of 294,707 US men aged 50-71 years in 1995-1996. Cox proportional hazards regression models with hazard ratios and 95% confidence intervals were adjusted for characteristics including age, race, body mass index, physical activity, and family history of prostate cancer, as well as testing for prostate-specific antigen and a digital rectal examination. There were 15,327 nonadvanced and 1,900 advanced prostate cancers identified through 2003 and 514 fatal cases through 2005. Risk of nonadvanced prostate cancer was 25% higher for men consuming ≥6 drinks daily (hazard ratio = 1.25, 95% confidence interval: 1.13, 1.37), 19% higher for men consuming 3-<6 drinks daily, and 6% higher for men consuming up to 3 drinks daily, compared with nondrinkers. The association between alcohol consumption and nonadvanced prostate cancer risk did not differ appreciably by age, family history of prostate cancer, smoking status, body mass index, or self-reported prostate-specific antigen testing and digital rectal examination (the latter available for >60% of respondents). The authors observed no association between alcohol intake and advanced prostate cancer and an inverse association with fatal prostate cancer among heavy drinkers. These findings suggest that higher alcohol consumption modestly increases nonadvanced prostate cancer risk.
Watters
Joanne L
JL
Nutritional Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland 20892, USA. wattersj@mail.nih.gov
Park
Yikyung
Y
Hollenbeck
Albert
A
Schatzkin
Arthur
A
Albanes
Demetrius
D
D017677:Age Distribution; D000368:Aged; D000428:Alcohol Drinking / Q000009:adverse effects* / Q000453:epidemiology; D000434:Alcoholic Beverages / Q000009:adverse effects*; D016001:Confidence Intervals; D005500:Follow-Up Studies; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D016016:Proportional Hazards Models; D011446:Prospective Studies; D017430:Prostate-Specific Antigen / Q000097:blood; D011471:Prostatic Neoplasms / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology*; D012307:Risk Factors; D015996:Survival Rate / Q000639:trends; D014481:United States / Q000453:epidemiology
D017430:Prostate-Specific Antigen
Cancer Epidemiol Biomarkers Prev. 2008 May;17(5):1282-7
18483352
Am J Epidemiol. 2001 Dec 15;154(12):1119-25
11744517
Int J Cancer. 2007 Apr 1;120(7):1529-35
17211860
Int J Epidemiol. 2001 Aug;30(4):749-55
11511598
Cancer Causes Control. 2009 Aug;20(6):877-86
19277882
Nutr J. 2004 Dec 09;3:23
15588306
Am J Epidemiol. 2004 Mar 1;159(5):444-53
14977640
Gut. 1977 Oct;18(10):843-53
590844
Int J Cancer. 2005 Jan 1;113(1):133-40
15386436
Int J Cancer. 2006 Sep 15;119(6):1501-4
16615108
Br J Cancer. 2001 Nov 30;85(11):1700-5
11742491
J Natl Cancer Inst. 1996 Aug 21;88(16):1118-26
8757191
Ann Epidemiol. 1999 May;9(4):254-61
10332931
Am J Epidemiol. 1996 Apr 1;143(7):692-7
8651231
Cancer Causes Control. 2001 Sep;12(7):589-98
11552706
Lancet Oncol. 2006 Feb;7(2):149-56
16455479
Prostate. 2000 Jan;42(1):56-66
10579799
Am J Epidemiol. 1991 Apr 15;133(8):810-7
2021148
Epidemiol Rev. 2001;23(1):110-4
11588834
N Engl J Med. 1976 Oct 7;295(15):793-7
958274
Int J Cancer. 2010 Jan 1;126(1):171-9
19521962
Ann Epidemiol. 2000 Aug;10(6):361-9
10964002
Mol Nutr Food Res. 2009 Feb;53(2):240-55
19156715
Cancer Res. 2003 Dec 1;63(23):8542-8
14679023
J Natl Cancer Inst. 2008 Feb 6;100(3):170-83
18230794
Cancer Epidemiol Biomarkers Prev. 2009 Sep;18(9):2427-35
19706848
Nutr Cancer. 2006;56(1):50-6
17176217